top of page

Srikanth Suryadevara

Senior .NET Developer and Technical Lead

Srikanth Suryadevara is a highly experienced Senior .NET Developer and Technical Lead with over 12 years of expertise in designing, developing, and maintaining robust applications and systems. Proficient in a wide range of .NET frameworks, C#, ASP.NET, angular and related Microsoft technologies, Srikanth Suryadevara has a proven track record of leading technical teams, architecting solutions, and driving innovation in complex software projects.

With a deep understanding of software development life cycles, he excels in delivering scalable, high-performance solutions that meet both technical and business requirements. As a technical lead, Srikanth Suryadevara fosters collaboration and mentorship within teams, ensuring code quality, efficient workflows, and adherence to best practices. His passion for problem-solving, commitment to continuous learning, and ability to adapt to emerging technologies have consistently resulted in successful project outcomes and satisfied clients.

Srikanth  Suryadevara holds a unique interdisciplinary background, combining a Bachelor of Pharmacy with a Master’s degree in Computer Science and Information Technology, positioning him at the intersection of healthcare and technology. This blend of expertise enables Srikanth Suryadevara to bridge the gap between pharmaceutical sciences and cutting-edge technological innovations.

Building on his pharmaceutical foundation, Srikanth Suryadevara pursued a deeper understanding of computer science, with a special focus on the integration of Artificial Intelligence (AI) within healthcare systems, particularly in pharmacy. His research explores the transformative potential of AI in optimizing pharmaceutical processes, including drug discovery, personalized medicine, and patient care optimization. By leveraging AI technologies such as machine learning, natural language processing, and predictive analytics, Srikanth Suryadevara is dedicated to advancing the future of pharmacy by driving efficiencies in drug development, improving diagnostic accuracy, and enhancing therapeutic outcomes.

Srikanth Suryadevara
bottom of page